SCHEMBL8871768

SCHEMBL8871768

COc1cc2[nH]cnc(=O)c2c([N+](=O)[O-])c1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ GRIN2D O15399 3/20 0.39
▸ GRIN3B O60391 3/20 0.39
▸ GRIN1 Q05586 3/20 0.39
▸ GRIN2A Q12879 3/20 0.39
▸ GRIN2B Q13224 3/20 0.39
▸ GRIN2C Q14957 3/20 0.39
▸ GRIN3A Q8TCU5 3/20 0.39
▸ BRD4 O60885 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ TUBB4A P04350 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1805778 0.82 BRD4 (0.43) ALDH1A1KDM4EGRIN2DGRIN3BGRIN1
SCHEMBL5793230 0.79 BRD4 (0.42) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1468319 0.79 TNF (0.46) TNFMCL1KMT2AMEN1PKM
SCHEMBL1806677 0.78 BRD4 (0.41) TNFGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17181572 0.77 MCL1 (0.42) MCL1PKMALDH1A1KDM4EMAPT
SCHEMBL7412357 0.73 MCL1 (0.43) TNFMCL1KMT2APKMALDH1A1
SCHEMBL30833892 0.72 PKM (0.53) TNFMCL1KMT2AMEN1PKM
SCHEMBL27803052 0.72 PKM (0.53) TNFMCL1KMT2AMEN1PKM
SCHEMBL30166025 0.72 PKM (0.53) TNFMCL1KMT2AMEN1PKM
SCHEMBL11485721 0.71 KMT2A (0.49) KMT2AMEN1ALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616582-A Use as anticancer agents; e.g. gefitinib ZENECA LIMITED (GB) 1997-04-01 — — US disclosed
EP-0566226-B1 Quinazoline derivatives ZENECA LTD (GB) 1995-11-08 — — EP disclosed
US-5457105-A anticancer use; e.g. 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline (gefitinib) ZENECA LIMITED (GB) 1995-10-10 — — US disclosed
EP-0566226-A1 Quinazoline derivatives ZENECA LIMITED (GB) 1993-10-20 — — EP disclosed
Send feedback